A Phase II, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial Evaluating the Role of an Empiric 2-Week Course of Ciprofloxacin on Rates of Detection of Cancer by Prostate Biopsy in Men With Abnormal Serum Prostate Specific Antigen Found at Screening (PREP Trial)

Trial Profile

A Phase II, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial Evaluating the Role of an Empiric 2-Week Course of Ciprofloxacin on Rates of Detection of Cancer by Prostate Biopsy in Men With Abnormal Serum Prostate Specific Antigen Found at Screening (PREP Trial)

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 05 Aug 2017

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms PREP
  • Most Recent Events

    • 28 Jul 2017 Planned End Date changed from 1 Jul 2016 to 31 Jul 2016.
    • 28 Jul 2017 Planned primary completion date changed from 1 Dec 2018 to 31 Jul 2016.
    • 28 Jul 2017 Planned initiation date changed from 1 Dec 2015 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top